
    
      This study consists of three parts. Part 1 and Part 3 are a single ascending and multiple
      dose study to assess the safety, pharmacokinetics and pharmacodynamics of DS-2741a after
      subcutaneous injection in healthy Japanese male participants. Part 2 is a single-dose study
      to assess the pharmacokinetics, safety, pharmacodynamics and efficacy of DS-2741a after
      subcutaneous injection in Japanese participants with moderate to severe atopic dermatitis.
    
  